Research Explorer

Project

Generation, validation and application of nanobodies directed against the neovascular integrins alpha V and Beta 3 in cancer therapie
Code
365B2307
Looptijd
01-01-2007 → 31-12-2010
Financiering
Funding by bilateral agreement (private and foundations)
Onderzoeksdisciplines
  • Medical and health sciences
    • Immunology
    • Morphological sciences
    • Oncology
    • Immunology
    • Morphological sciences
    • Oncology
    • Immunology
    • Morphological sciences
    • Oncology
Trefwoorden
antilichamen therapie kanker
 
Projectomschrijving

Research in this project is based on the finding that the integrins alphaV and Beta3 are expressed by cancerous endothelium and wound tissue specifically. The aim of the project is to destroy tumors by small antibodies that block these integrins.